TELMISTRUM CH 6.25 Mg Tablet : Uses, Benefits, Dosage, Price & Side Effects and more information.....

TELMISTRUM CH 6.25, manufactured by Steris Healthcare, is a dual-action antihypertensive combination formulated with Telmisartan 40 mg and Chlorthalidone 6.25 mg. This fixed-dose combination brings together an angiotensin receptor blocker (Telmisartan) with a low-dose, long-acting thiazide-like diuretic (Chlorthalidone) in a single tablet, designed for the long-term management of hypertension in adults who need combination therapy but benefit from a gentler diuretic dose than higher-strength alternatives provide.

Why It's Important

Hypertension is often described as a "silent" condition because it typically produces no obvious symptoms while steadily damaging blood vessels, the heart, kidneys, and brain over years of sustained exposure. Left uncontrolled, persistently high blood pressure significantly increases the risk of heart attack, stroke, chronic kidney disease, and other serious cardiovascular complications. A substantial proportion of hypertensive patients cannot achieve adequate control with a single antihypertensive agent alone, which is why combination therapy has become a cornerstone of modern hypertension management — but not every patient tolerates or requires a full-strength diuretic dose.

This is exactly where Telmisartan 40 mg combined with the lower Chlorthalidone 6.25 mg strength demonstrates real clinical value. Telmisartan works by blocking the angiotensin II receptor, preventing a hormone that constricts blood vessels and raises blood pressure from exerting its effect, while also offering renal-protective benefits relevant to patients with diabetes or early kidney involvement. Chlorthalidone, even at this lower 6.25 mg dose, contributes meaningful additional blood pressure reduction through its diuretic action, while minimizing the electrolyte disturbances and metabolic side effects that can sometimes accompany higher-dose thiazide-like diuretic therapy. This makes TELMISTRUM CH 6.25 a particularly useful option for patients who need the added benefit of a diuretic but are more sensitive to its effects — such as elderly patients, those with borderline electrolyte levels, or patients who experienced side effects on higher-strength combinations. By combining two complementary mechanisms — hormonal and renal — at a carefully balanced dose, this formulation offers effective blood pressure control with an emphasis on tolerability.

Key Benefits 

What Are the Benefits of This Combination?

• Provides effective blood pressure reduction through two complementary mechanisms — hormonal (angiotensin II blockade) and renal (mild diuretic action)
• Lower 6.25 mg Chlorthalidone dose reduces the risk of electrolyte disturbances compared to higher-strength diuretic combinations
• Suitable for patients who need combination therapy but are sensitive to standard-dose diuretics, including elderly patients
• Once-daily dosing supports better long-term treatment adherence and simplifies the medication routine
• Chlorthalidone's long duration of action supports more consistent blood pressure control across the full 24-hour dosing interval
• Helps counteract mild fluid retention that can occasionally occur with ARB monotherapy, through gentle diuretic support
• Offers a useful step-up option for patients not adequately controlled on Telmisartan alone but who prefer a milder diuretic exposure
• Reduces overall pill burden by combining two complementary antihypertensive mechanisms into a single tablet

Side Effects

Like all antihypertensive combinations, TELMISTRUM CH 6.25 may cause side effects in some patients, particularly during the initial weeks of treatment as the body adjusts. Commonly reported effects include mild dizziness, headache, fatigue, slightly increased urination, mild gastrointestinal discomfort, and occasional muscle cramps. Because of the lower Chlorthalidone dose, these effects are often milder and less frequent than with higher-strength diuretic combinations, though they can still occur and generally improve as treatment continues.

Available Substitutes

Several fixed-dose combinations of Telmisartan and Chlorthalidone are available in the Indian pharmaceutical market at varying strengths — commonly Chlorthalidone 6.25 mg or 12.5 mg paired with Telmisartan 40 mg or 80 mg. Patients should not switch between different strength combinations without consulting their physician, as even the difference between the 6.25 mg and 12.5 mg Chlorthalidone dose can meaningfully affect both blood pressure control and tolerability. For a Steris Healthcare-manufactured alternative or a different strength, patients and PCD franchise partners are encouraged to consult the company's product portfolio directly.

Dosage Guidelines 

Dosage must always be individualized by a physician based on the patient's baseline blood pressure, response to prior Telmisartan monotherapy, tolerance for diuretic therapy, and any coexisting medical conditions. TELMISTRUM CH 6.25 is typically taken once daily, at the same time each day, with or without food, to help maintain steady drug levels and support consistent treatment adherence. Tablets should be swallowed whole with a glass of water and should not be crushed or chewed unless otherwise directed. Patients should not stop this medication abruptly or skip doses, as blood pressure control depends on consistent daily use; any dosage adjustments should be made only under medical supervision, typically alongside periodic blood pressure and electrolyte monitoring.

Precautions & Warnings

TELMISTRUM CH 6.25 should not be used in patients with a known hypersensitivity to Telmisartan, Chlorthalidone, or sulfonamide-derived drugs, and is contraindicated in anuria (inability to produce urine) and severe renal impairment. It is also contraindicated during pregnancy due to the risk of fetal harm associated with angiotensin receptor blockers, particularly in the second and third trimesters. It should be used with caution in patients with severe hepatic or biliary obstruction, gout, and diabetes, as thiazide-like diuretics may mildly affect uric acid levels and glucose tolerance even at lower doses. Elderly patients may be more sensitive to blood pressure–lowering and electrolyte effects, and should be monitored accordingly. Patients should inform their physician of all other medications being taken, including NSAIDs, lithium, other diuretics, and potassium supplements, to avoid potentially serious interactions. Regular monitoring of blood pressure, kidney function, and electrolyte levels is generally recommended during long-term therapy.

How to Use & Mechanism of Action

TELMISTRUM CH 6.25 should be taken orally, once daily at a consistent time, swallowed whole with a glass of water, with or without food. Its effectiveness comes from the complementary mechanisms of its two components. Telmisartan 40 mg, an angiotensin II receptor blocker (ARB), works by selectively blocking the AT1 receptor, preventing angiotensin II — a hormone responsible for constricting blood vessels and stimulating aldosterone release — from exerting its effects, resulting in sustained vasodilation and additional renal-protective benefits. Chlorthalidone 6.25 mg, a thiazide-like diuretic used here at a lower dose, works at the distal convoluted tubule of the kidney nephron, inhibiting sodium and chloride reabsorption. Even at this reduced strength, Chlorthalidone contributes meaningful additional sodium and water excretion, helping to reduce blood volume and support blood pressure control, while its lower dose helps minimize the risk of electrolyte disturbances that can occur at higher diuretic strengths. Together, Telmisartan's hormonal blockade and Chlorthalidone's gentle but sustained diuretic action attack blood pressure elevation from two separate physiological angles, offering effective control with a tolerability-focused dosing approach.

chlorthalidone 6.25 mg uses in hindi: क्लोर्थैलिडोन 6.25 mg एक कम मात्रा वाला थियाज़ाइड-जैसा मूत्रवर्धक (डाइयुरेटिक) है, जिसका उपयोग हाई ब्लड प्रेशर को नियंत्रित करने के लिए किया जाता है। यह शरीर से अतिरिक्त सोडियम और पानी को बाहर निकालने में मदद करता है, जिससे रक्तचाप कम होता है। इसकी कम मात्रा के कारण, यह इलेक्ट्रोलाइट असंतुलन के जोखिम को कम करता है, जबकि टेल्मिसर्टन के साथ मिलकर प्रभावी रक्तचाप नियंत्रण प्रदान करता है। इस दवा का उपयोग हमेशा डॉक्टर की सलाह के अनुसार ही करना चाहिए।

Frequently Asked Questions

1. What is TELMISTRUM CH 6.25 used for?
TELMISTRUM CH 6.25 is used for the long-term management of high blood pressure in adults who need combination therapy with a gentler diuretic dose than higher-strength alternatives.

2. What is telmisartan and chlorthalidone tablets uses?
This combination is used to treat hypertension by relaxing blood vessels through hormonal blockade while also providing mild additional fluid reduction through diuretic action.

3. What is telmisartan tablet used for?
Telmisartan tablets are used to treat high blood pressure by blocking angiotensin II receptors, which helps relax and widen blood vessels.

4. What is chlorthalidone tablet uses?
Chlorthalidone tablets are used as a diuretic to lower blood pressure by helping the kidneys excrete excess sodium and water from the body.

5. What is chlorthalidone 6.25 mg used for specifically?
Chlorthalidone 6.25 mg is a lower-dose diuretic option, typically used in combination with an ARB like Telmisartan to provide additional blood pressure control while minimizing diuretic-related side effects.

6. Is TELMISTRUM CH 6.25 safe for daily long-term use?
When prescribed and monitored by a physician, TELMISTRUM CH 6.25 is generally considered safe for long-term daily use in managing chronic hypertension.

7. Can telmisartan and chlorthalidone be taken together?
Yes, this fixed-dose combination is specifically formulated to be taken together, as the two components target blood pressure through complementary, non-overlapping mechanisms.

8. What is the best time to take TELMISTRUM CH 6.25?
It is generally recommended to take this medication at the same time each day, with or without food, as advised by your physician, to maintain consistent blood pressure control.

9. Why would a doctor prescribe the 6.25 mg Chlorthalidone strength instead of 12.5 mg?
The lower 6.25 mg strength is typically chosen for patients who need a milder diuretic effect, such as elderly patients or those at higher risk of electrolyte disturbances.

10. Is chlorthalidone 6.25 mg less likely to cause side effects than higher doses?
Generally, yes — the lower dose is associated with a reduced risk of electrolyte disturbances and metabolic side effects compared to higher-strength Chlorthalidone formulations, though individual response can vary.

11. What should I do if I miss a dose of TELMISTRUM CH 6.25?
If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next scheduled dose — in that case, skip the missed dose rather than doubling up, and consult your physician if unsure.

12. Is TELMISTRUM CH 6.25 safe during pregnancy?
No, medications containing Telmisartan are contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm. Physicians typically switch to alternative antihypertensives if pregnancy is planned or confirmed.

13. What are the common side effects of telmisartan and chlorthalidone 6.25 mg tablets?
Common side effects include mild dizziness, headache, fatigue, slightly increased urination, and occasional muscle cramps, most of which are mild given the lower diuretic dose.

14. Can chlorthalidone affect blood sugar or uric acid levels even at 6.25 mg?
Yes, although the risk is generally lower at this reduced dose, thiazide-like diuretics can still mildly affect glucose tolerance and uric acid levels, so patients with diabetes or gout should still be monitored.

15. How long does it take for TELMISTRUM CH 6.25 to control blood pressure?
Blood pressure reduction is typically noticeable within one to two weeks, though the full therapeutic effect may take several weeks of consistent daily use to stabilize.

16. Can this medication cause dehydration or electrolyte imbalance?
The risk is lower than with higher-dose diuretic combinations, but patients should still stay adequately hydrated and undergo periodic electrolyte monitoring, particularly during hot weather or illness involving fluid loss.

17. Can TELMISTRUM CH 6.25 be stopped suddenly?
No, this medication should not be stopped abruptly, as doing so can lead to a rebound rise in blood pressure. Any discontinuation should be gradual and supervised by a physician.

Conclusion

TELMISTRUM CH 6.25 by Steris Healthcare brings together the complementary mechanisms of Telmisartan 40 mg and a carefully measured lower dose of Chlorthalidone 6.25 mg to offer effective, well-tolerated, once-daily hypertension management. By addressing blood pressure elevation through two distinct physiological pathways — hormonal receptor blockade and gentle diuretic action — this combination is particularly well-suited for patients who need added blood pressure support beyond Telmisartan monotherapy but who benefit from a milder diuretic exposure, such as elderly patients or those with borderline electrolyte levels. As with any antihypertensive combination therapy, treatment should be initiated and monitored under medical supervision, with regular blood pressure, kidney function, and electrolyte checks to ensure long-term safety and effectiveness.

For Further Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now